GConferenceGridThe Conference Catalogue · Vol. 2026Folio № D5BEC4
Healthcare & Medical

Medicinal Chemistry Summer School 2026

T

he Royal Society of Chemistry Medicinal Chemistry Summer School 2026 covers topics of interest to drug discovery researchers, increasing understanding of the factors that govern modern drug discovery from concept through translational science and intellectual property. Since 1981, the Summer School has trained many of the world’s leading medicinal chemists…

Visit the official site
16Voices
0Underwriters
0Exhibitors
27On the bill · sessions
12Companies · in total
§I

The Voices

Programmed at Medicinal, in alphabetical order.
Andrew Cook
AstraZeneca
Andy Davis
AstraZeneca
Britta Bonn
Ribocure Pharmaceuticals
Cheryl Doherty
GSK
Darren Green
DesignPlus CC
Emma Rivers
AstraZeneca
Janet Brownlees
MSD
Jeremy Burrows
Medicines for Malaria Venture
Matthew James Thomas
Boehringer Ingelheim Pharma GmbH & Co. KG
Mike Kelly
Anjin Preclinical Ltd
Nicola Colclough
AstraZeneca
Ruth Lock
Aucuba Sciences Ltd
Sarah Skerratt
Isomorphic Labs
Simon Hirst
Sygnature Discovery
Simon Ward
Draig Therapeutics
Zoë Henley
GSK
§III

The Programme

Selected from 27 sessions on the bill.
  • Friday 12 June 08:30

    Preparation time for in-licensing case study

  • Friday 12 June 09:30

    Presentations of the in-licensing case study

  • Friday 12 June 10:45

    Summary of the in-licensing case study

  • Friday 12 June 11:30

    Case study: TBC

  • Friday 12 June 12:30

    Course summary

  • Monday 08 June 08:45

    Course introduction

  • Monday 08 June 09:00

    Lecture: Drug metabolism and the fate of drugs

  • Monday 08 June 11:00

    Lecture: An introduction to pharmacokinetics

  • Monday 08 June 13:30

    Lecture: Controlling physicochemical properties for small molecule drug design

Intermission
Part the Second · For the Buyer

An audience of 12 companies, parsed from the program.

“Twelve companies in attendance.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
0All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
12Speakingspeaker only
№ 02Fig. 02 — The Voices, by Seniority
  • Other roles16100%

Of 16 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01AstraZeneca4V
  2. 02GSK2V
  3. 03Anjin Preclinical Ltd1V
  4. 04Aucuba Sciences Ltd1V
  5. 05Boehringer Ingelheim Pharma GmbH & Co. KG1V
  6. 06DesignPlus CC1V
  7. 07Draig Therapeutics1V
  8. 08Isomorphic Labs1V
  9. 09Medicines for Malaria Venture1V
  10. 10MSD1V
  11. 11Ribocure Pharmaceuticals1V
  12. 12Sygnature Discovery1V
№ 04Fig. 04 — By Tier

Tiers were not disclosed for this convocation.